SLC7A11 and cancer: The activation of cellular glucose metabolism by the MYC oncoprotein has been shown to enhance the production of NADPH, which may serve as a reducing agent to facilitate the resolution of disulfide bonds, thus suppressing disulfidptosis in cancer cells characterized by high levels of SLC7A11[33].